Elevai Labs, Common Stock (ELAB) Revenue
Market Cap: $3.26M
Avg Volume: 268.39K
Industry: Biotechnology
Sector: Healthcare
What is Elevai Labs, Common Stock's Revenue?
Elevai Labs, Common Stock's quarterly revenue as of Q3 2024 is $527.48K.
Elevai Labs, Common Stock's annual revenue for the fiscal year 2023 is $1.71M.
Related metrics for Elevai Labs, Common Stock (quarterly):
- Cost of Revenue: $133.58K
- Gross Profit: $393.90K
- Gross Profit Ratio: 74.68%
- Revenue Per Share: $0.02
- Revenue Growth: -12.89%
Apple's quarterly revenue was $527.48K, with a cost of revenue of $133.58K, which leaves $393.90K gross profit and a gross profit ratio of 74.68%.
Related metrics for Elevai Labs, Common Stock (annual):
- Cost of Revenue: $578.01K
- Gross Profit: $1.13M
- Gross Profit Ratio: 66.25%
- Revenue Per Share: $0.16
- Revenue Growth: 123.50%
Apple's annual revenue was $1.71M, with a cost of revenue of $578.01K, which leaves $1.13M gross profit and a gross profit ratio of 66.25%.
Understanding Revenue
Revenue is the total amount of income generated by the sale of goods or services related to the company's primary operations. It is often referred to as the "top line" because it sits at the top of the income statement.
End of Year Revenue
The table below shows the revenue for each fiscal year, with the latest data available for 2023.
| Year | Revenue | Change |
|---|---|---|
| 2023 | $1.71M | 123.50% |
| 2022 | $766.28K | 92557.44% |
| 2021 | $827 | N/A |
| 2020 | $- | N/A |
Related Metrics
Explore detailed financial metrics and analysis for ELAB.